Silica Corpora
Curated by SignalAI-powered provider of biosuperior antibodies designed for drug discovery
Overview
AI-powered provider of biosuperior antibodies designed for drug discovery. The company offer a modular software platform with AI solutions for therapeutic antibody design and optimization tasks for lead generation and optimization of antibody development.
Key facts
- Founded
- 2022
- Headquarters
- Berlin, Germany
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 2 products and services
- Sign up to view